MRI-based measures of brain and lesion volume change show utility as markers of disability progression in MS patients, Australian researchers have shown. The Neurological Software Tool for REliable Atrophy Measurement (NeuroSTREAM) software, that computes cross-sectional and longitudinal lateral ventricular volume (LVV) and salient central lesion volume (SCLV), was applied to 5,750 brain scans from 1,875 ...
Brain atrophy and lesion burden changes linked to disease progression in MS
By Mardi Chapman
30 Aug 2021